EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

American Cutaneous Leishmaniasis: Imported cases in Berlin 2000–2023

Andreas K Lindner iD, Maria Cristina Moreno-Del Castillo, Mia Wintel, Gabriela Equihua Martinez, Joachim Richter, Florian Kurth, Frieder Pfäfflin, Thomas Zoller, Maximilian Gertler, Susanne Georgi, Michael Nürnberg, Claudia Hülso und 7 weitere

PLOS Neglected Tropical Diseases · 15.07.2024 · 18 (7) · e0012323

DOI: 10.1371/journal.pntd.0012323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 15.07.2024. Verfasst von Andreas K Lindner und 18 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité Center for Global Health…. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Antiprotozoal Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

American Cutaneous Leishmaniasis (ACL) shows variable response to therapy, but data on species-specific treatment efficacy is scarce. We describe the clinical characteristics and outcome of patients with ACL imported to a tertiary centre in Germany and determine whether species-specific therapy according to the 2014 “LeishMan” group recommendations is associated with cure.

Methods

A retrospective chart review was conducted at the Charité Institute of International Health in Berlin. We analysed data on PCR-confirmed ACL cases collected between 2000 and 2023. Systemic therapy included liposomal amphotericin B, miltefosine, pentavalent antimony, ketoconazole or itraconazole. Localized therapy included perilesional pentavalent antimony or paromomycin ointment. Cure was defined as re-epithelialization of ulcers or disappearance of papular-nodular lesions after 3 months of treatment. Logistic regression models were used to quantify the effect of species-specific systemic therapy on the outcome.

Results

75 cases were analysed. Most patients were male (62%), median age was 35 years, no patient had a history of immunosuppression. The most common reason for travel was tourism (60%), the most common destination was Costa Rica (28%), the median duration of illness was 8 weeks, and most patients presented with ulcers (87%). Lesions were complex in 43%. The most common Leishmania (L.) species was L . braziliensis (28%), followed by L . panamensis (21%). 51/73 (70%) patients were cured after initial therapy and 17/21 (81%) after secondary therapy. Cure after systemic therapy was more frequent when species-specific treatment recommendations were followed (33/45; 73%), compared to when not followed, (6/17; 35%, P = 0.008). This association was independent of age, sex, previous therapy, complex lesions, and Leishmania species (adjusted OR, 5.06; 95% CI, 1.22–24.16).

Conclusions

ACL is a rare, imported disease in Germany. Complex lesions were common, challenging successful therapy. This study highlights the importance of identifying the parasite species and suggests that a species-specific approach to treatment leads to better outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, CutaneousAntiprotozoal AgentsHumansMaleFemaleAdultRetrospective StudiesMiddle AgedYoung AdultBerlinAdolescentTreatment OutcomeAmphotericin BTravelCommunicable Diseases, ImportedAgedLeishmaniaChildPhosphorylcholine

Substanzen

Antiprotozoal Agentsliposomal amphotericin BAmphotericin BmiltefosinePhosphorylcholine

Autor:innen und Institutionen

  • Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité Center for Global Health, Institute of International Health, Berlin, Germany.
  • Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory and Critical Care Medicine, Berlin, Germany.

ORCID-Profile: Andreas K Lindner, Beate Kampmann

Zitieren

APA

Lindner, A. K., Moreno-Del Castillo, M. C., Wintel, M., Equihua Martinez, G., Richter, J., Kurth, F., Pfäfflin, F., Zoller, T., Gertler, M., Georgi, S., Nürnberg, M., Hülso, C., Bernhard, J., Kotsias, S. K., Seigerschmidt, A., van Loon, W., Mockenhaupt, F., Kampmann, B., & Harms, G. (2024). American Cutaneous Leishmaniasis: Imported cases in Berlin 2000–2023. PLOS Neglected Tropical Diseases, 18(7), e0012323. https://doi.org/10.1371/journal.pntd.0012323

Vancouver

Lindner AK, Moreno-Del Castillo MC, Wintel M, Equihua Martinez G, Richter J, Kurth F, et al. American Cutaneous Leishmaniasis: Imported cases in Berlin 2000–2023. PLOS Neglected Tropical Diseases. 2024;18(7):e0012323. doi:10.1371/journal.pntd.0012323

BibTeX
@article{Lindner2024,
  author = {Lindner, Andreas K and Moreno-Del Castillo, Maria Cristina and Wintel, Mia and Equihua Martinez, Gabriela and Richter, Joachim and Kurth, Florian and Pfäfflin, Frieder and Zoller, Thomas and Gertler, Maximilian and Georgi, Susanne and Nürnberg, Michael and Hülso, Claudia and Bernhard, Julian and Kotsias, Sarah Konopelska and Seigerschmidt, Antonio and van Loon, Welmoed and Mockenhaupt, Frank and Kampmann, Beate and Harms, Gundel},
  title = {American Cutaneous Leishmaniasis: Imported cases in Berlin 2000–2023},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  volume = {18},
  number = {7},
  pages = {e0012323},
  doi = {10.1371/journal.pntd.0012323}
}
Kostenlos starten →